Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and captioned circular, Nectar Lifesciences has informed that it enclosed the disclosure on Related Party Transactions for half year period from October 01, 2021 to March 31, 2022.
The above information is a part of company’s filings submitted to BSE.